Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Opko Health Inc. logo

Opko Health Inc.

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

1.25
 
USD
  
0.00
  
(0.00%)
Optionable: Yes  Market Cap: 920 M  90-day average vol: 6,388,779

Previous close: 1.25  Open: 1.22  Bid: 1.24  Ask: 1.26
52 week range    
0.85   
   2.24
Last updated: Tuesday 18th June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

OPK Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles11 M28 M64 M71 M68 M65 M56 M50 M88 M86 M
Basic EPS from continuing operations-0.41-0.06-0.05-0.530.05-0.05-0.46-0.25
Basic EPS total-0.41-0.06-0.05-0.55-0.27-0.530.05-0.05-0.46-0.25
Basic weighted shares outstanding422 M488 M551 M559 M563 M595 M641 M648 M719 M752 M
Cost of sales48 M235 M611 M-61 M-58 M511 M824 M1,102 M628 M446 M
Depreciation-15 M-42 M-97 M-102 M-97 M94 M85 M79 M109 M105 M
Depreciation unreconciled11 M28 M64 M71 M68 M65 M56 M50 M88 M86 M
DepreciationAndAmortization11 M28 M64 M71 M68 M65 M56 M50 M88 M86 M
Diluted EPS total-0.12-0.06-0.04-0.55-0.13-0.530.05-0.05-0.46-0.25
Diluted normalized net income/share-0.12-0.04-0.05-0.46
Diluted weighted shares outstanding422 M488 M551 M559 M1,177 M595 M641 M648 M719 M752 M
Earnings from equity interest-4 M-7 M-8 M-14 M-14 M-63 M-480000.0-629000.0-383000.0-107000.0
EarningsFromEquityInterestNetOfTax-4 M-7 M-8 M-14 M-14 M-63 M-480000.0-629000.0-383000.0-107000.0
GainOnSaleOfPPE32 M19 M
GainOnSaleOfSecurity-11 M-39 M3 M52000.03 M174000.050000.0846000.0649000.0-781000.0
GeneralAndAdministrativeExpense58 M197 M491 M-19 M-19 M343 M356 M469 M373 M301 M
Gross operating profit43 M256 M610 M346 M386 M391 M612 M673 M377 M418 M
ImpairmentOfCapitalAssets13 M22 M92 M
Income before tax-175 M-145 M-81 M-272 M-177 M-305 M49 M-14 M-392 M-184 M
Income restructuring and M&A-10 M-1000000.0-1 M-2 M-5 M
Income taxes24000.0-114 M-56 M19 M-39 M7 M18 M15 M-63 M4 M
Interest income-6 M-11 M2 M4 M
InterestExpenseNonOperating3 M3 M2 M12 M14 M
InterestExpenseOperating-9 M-7 M-8 M
MinorityInterests3 M1 M
MiscOtherSpecialCharges-15 M-434000.0-3 M10 M2 M-31 M-9 M-34 M-156 M-17 M
Net income from total operations-172 M-30 M-25 M-305 M-153 M-315 M31 M-30 M-328 M-189 M
NetIncomeCommonStockholders-172 M-30 M-25 M-305 M-153 M-315 M31 M-30 M-328 M-189 M
NetIncomeContinuousOperations-172 M-30 M-25 M-305 M-153 M-315 M31 M-30 M-328 M-189 M
NetIncomeFromOtherGainsLosses-14 M-3 M-480000.0
NetNonOperatingInterestIncomeExpense-6 M-11 M-3 M-3 M-2 M-10 M-10 M
Normalized income-149 M
Operating income-121 M-93 M-56 M-267 M-166 M-274 M58 M19 M-226 M-157 M
Operating income before depreciation (EBITDA)-158 M-102 M16 M-170 M-80 M-207 M138 M59 M-277 M-72 M
OperatingExpense164 M350 M667 M-1,242 M-1,161 M1,176 M1,378 M1,756 M1,230 M1,021 M
Other income net53 M52 M25 M539000.0-21 M16 M6 M193000.0136 M17 M
Other special charges9 M3 M3 M
OtherGandA58 M197 M491 M-19 M-19 M343 M356 M469 M373 M301 M
OtherImpairmentOfCapitalAssets0.0-13 M
OtherOperatingExpenses-237 M26 M-1,295 M-1,242 M-1,161 M-884000.0-441000.0-166000.0-4 M-4 M
OtherunderPreferredStockDividend0.0
PreferredStockDividends0.0
RentAndLandingFees-3 M-8 M-19 M-19 M-19 M
Research & development expense96 M99 M111 M126 M126 M118 M75 M77 M74 M90 M
ResearchExpense96 M99 M111 M126 M126 M118 M75 M77 M74 M90 M
RestructringAndMnAIncome-10 M-1000000.0-1 M-2 M-5 M
Revenue per share11 M28 M64 M71 M68 M65 M56 M50 M88 M86 M
SalariesAndWages-15 M-26 M-43 M-28 M-22 M13 M9 M14 M
Selling Gen & administrative expense58 M197 M491 M415 M358 M343 M356 M469 M373 M301 M
SellingAndMarketingExpense415 M358 M
SellingExpense415 M358 M
Special income/charges-13 M-22 M-92 M-7 M-3 M2 M
Total Income available for interest expense (EBIT)-175 M-145 M-81 M-272 M-177 M-302 M52 M-20 M-387 M-179 M
Total common shares outstanding452 M546 M558 M559 M616 M670 M670 M681 M773 M697 M
Total net income-172 M-30 M-25 M-305 M-153 M-315 M31 M-30 M-328 M-189 M
Total ordinary shares697 M697 M697 M697 M697 M697 M697 M697 M697 M697 M
Total revenues91 M492 M1,222 M966 M990 M902 M1,435 M1,775 M1,004 M863 M
TotalExpenses212 M585 M1,278 M-1,304 M-1,219 M1,687 M2,202 M2,858 M1,858 M1,466 M
TotalRevenue91 M492 M1,222 M966 M990 M902 M1,435 M1,775 M1,004 M863 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University